Avellino, a biotech startup based in Seoul, has developed a pioneering technology that has so far protected over 460 people from losing their sight. Avellino Corneal Dystrophy is a genetic condition which weakens eyesight over time, leading to visual impairment or even total blindness. Avellino’s proprietary DNA testing solution has been used by over 460,000 patients prior to LASIK surgery, with the test determining the presence of the condition with 100% accuracy.

“Avellino Corneal Dystrophy is a point mutation, meaning that only one genetic sequence out of thousands has been affected. This makes it very difficult to detect with existing testing methods. While the test we have developed is based on traditional genetic sequencing, it is able to identify even this minor abnormality.” Chairman & CEO of Avellino Lab China Holdings Gene Lee said.

While there is currently no treatment for Avellino Cornea Dystrophy, the benefit of early detection has already saved the eyesight of over 460 patients, with this number growing as the test expands globally. The company has developed new DNA tests for other corneal dystrophies, with R&D focusing on the early detection of other important eye diseases. So far Avellino has contracted their technology to 64 clinics in the US alone and it is used in 40 countries worldwide. By collecting data from nearly 500,000 patients they have been able to test other hypotheses that will likely deliver benefits to a much wider group of patients, as well as the general public.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

Eva Yoo

Eva Yoo is Shanghai-based tech writer. Reach her at evayoo@technode.com